RECRUITING

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

Official Title

Serious Gaming for Chemotherapy-induced Nausea and Vomiting in Older Adults With Cancer: A Randomized Clinical Trial

Quick Facts

Study Start:2023-06-09
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05838638

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age 60 or older
  2. * newly diagnosed with cancer
  3. * treatment with any chemotherapeutic agent of moderate or high emetic potential
  4. * on a 2, 3 or 4 week treatment cycle
  5. * proficient in English
  6. * has a telephone
  1. * previous diagnosis and/or treatment for cancer
  2. * end stage disease with less than 6 months to live
  3. * visually or hearing impaired without corrective device

Contacts and Locations

Study Contact

Victoria Loerzel, PhD
CONTACT
407-823-0762
victoria.loerzel@ucf.edu
Michael Owings
CONTACT
407-440-1309
michaelowings@ucf.edu

Principal Investigator

Victoria Loerzel, PhD
PRINCIPAL_INVESTIGATOR
University of Central Florida

Study Locations (Sites)

Miller School of Medicine Sylvester Comp. Cancer Center
Miami, Florida, 33136
United States
Orlando Health
Orlando, Florida, 32806
United States

Collaborators and Investigators

Sponsor: University of Central Florida

  • Victoria Loerzel, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-09
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2023-06-09
Study Completion Date2027-06-30

Terms related to this study

Keywords Provided by Researchers

  • aged
  • digital technology
  • nausea
  • neoplasm
  • Drug related side effects and adverse reactions
  • self-management

Additional Relevant MeSH Terms

  • Neoplasms
  • Chemotherapy-induced Nausea and Vomiting